Activation of PPARα reduces cardiac hypertrophy, decreases cardiac fibrosis, attenuates cardiac dysfunction, and improves survival by inhibition of profibrotic, proinflammatory, and prohypertrophic genes [6]. This evidence concerns the gene PPARA and cardiac hypertrophy.